Newsroom
Subscribe
Contact
About us
About us
Company Overview
Team
Careers
Our Science
Our Science
Pipeline
Pipeline
Investors
Investors
Investor Overview
Press Releases
Events + Presentations
Company Information
SEC Filings
Stock Information
Corporate Governance
News Alerts
Press Releases
Overview
Press Releases
Events+Presentations
Company info
Stock Information
SEC Filings
Corp. governance
News Alerts
Recent Press Releases
June 5, 2023
Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates
May 30, 2023
Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023
May 24, 2023
Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug
May 22, 2023
Enveric Biosciences Announces Manuscript Detailing the Development of Novel Psilocin Prodrugs for the Treatment of Anxiety and Other Mental Health Disorders
May 19, 2023
Enveric Biosciences to Participate in 2023 BIO International Convention in Boston
May 18, 2023
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
View All
